Russia's cancer vaccine has successfully completed preclinical trials, demonstrating both safety and high efficacy, Veronika Skvortsova, head of Russia's Federal Medical and Biological Agency announced. "The research spanned several years, with...last three dedicated to mandatory preclinical studies...The vaccine is now ready for use; we're awaiting official approval," she added.